Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle c myc'

Search results for: 'research area cell cycle c myc'

Items 31-40 of 53

Page
per page
  1. CX-5461
    A8337 CX-5461
     2 Citation
    Summary: Pol I-mediated rRNA synthesis inhibitor
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  2. TH-302
    A3872 TH-302
    Summary: Hypoxia-activated prodrug,inhibits H460/HT29 cell growth
      ≥22.45 mg/mL
  3. Nelarabine
    A1379 Nelarabine
    Summary: Prodrug of ara-G for T-LBL/T-ALL
      insoluble in EtOH; ≥14.85 mg/mL
  4. Triapine
    B3209 Triapine
    Target: Ribonucleotide Reductases
    Summary: Ribonucleotide reductase inhibitor
      ≥83.33 mg/mL
  5. Trichostatin A (TSA)
    A8183 Trichostatin A (TSA)
     13 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; ≥15.12 mg/mL
  6. PCI-34051
    A4091 PCI-34051
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC8 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL
  7. NCH 51
    A4495 NCH 51
    Summary: Histone deacetylase (HDAC) inhibitor
  8. VAL-083
    A3902 VAL-083
    Summary: Bi-functional alkylating agent
      Soluble in DMSO
  9. Dacarbazine
    A2197 Dacarbazine
    Target: DNA Alkylating
    Summary: Antineoplastic( malignant melanoma and sarcomas)
      insoluble in EtOH; ≥0.54 mg/mL
  10. KD 5170
    A4493 KD 5170
     1 Citation
    Summary: HDAC inhibitor
      ≥21.2 mg/mL

Items 31-40 of 53

Page
per page